Subscribe
shutterstock_1436567156_jonathan_weiss
Jonathan Weiss / Shutterstock.com
6 November 2019Big PharmaSaman Javed

Takeda sells generics portfolio to Stada for $660m

German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails
27 August 2019   A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.
Big Pharma
Takeda sues Mylan over gout generic
5 December 2019   Takeda has sued Mylan for patent infringement and breach of a licencing agreement over Takeda’s Colcrys drug.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Big Pharma
Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails
27 August 2019   A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.
Big Pharma
Takeda sues Mylan over gout generic
5 December 2019   Takeda has sued Mylan for patent infringement and breach of a licencing agreement over Takeda’s Colcrys drug.

More on this story

Big Pharma
Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails
27 August 2019   A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.
Big Pharma
Takeda sues Mylan over gout generic
5 December 2019   Takeda has sued Mylan for patent infringement and breach of a licencing agreement over Takeda’s Colcrys drug.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers